FindTrial
Sign In

Liver Cancer data collection in Indian population .

An Observational study to see the clinical profile , laboratory abnormalities , imaging findings and outcome with standard medical treatments for Hepatocellular carcinoma: Towards development of a HCC registry .

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022387
Enrollment
500
Registered
2019-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

Asian Institute of Gastroenterology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with diagnosis of HCC either by imaging or by biopsy as per standard recommendation for diagnosis of HCC will be included in the study.

Exclusion criteria

Exclusion criteria: Patients unwilling to give informed consent for data collection.

Design outcomes

Primary

MeasureTime frame
To assess the etiology of HCC in Indian patients.Timepoint: 6, 12, 18, 24 months—

Secondary

MeasureTime frame
To record the stage of presentation, mode of presentation and outcomes of standard care of treatment.Timepoint: 6, 12, 18, 24 months—

Countries

India

Contacts

Public ContactDr Mithun Sharma

Asian Institute of Gastroenterology

drmithunsharma@gmail.com08790622655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026